Concept of total care: A third dimension in the treatment of psoriasis

Cutis

Volumn 59, Issue 1, 1997, Pages 35-39

  Farber, Eugene M ^a   Raychaudhuri, Siba Prasad ^a  

^a Psoriasis Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXERCISE; HUMAN; OBESITY; PATHOGENESIS; PSORIASIS; REVIEW; STRESS; SUBSTANCE ABUSE; TREATMENT PLANNING;

ADOLESCENT; ADULT; CHILD; EXERCISE; FEMALE; HUMANS; MALE; PATIENT EDUCATION; PSORIASIS; RISK FACTORS; SMOKING; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS;

EID: 0031031193     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Farber EM, Nall ML: The natural history of psoriasis in 5600 patients. Dermatologica 148: 1-18, 1974.
2. Fava GA, Perini GI, Santonaso P, Farnaso CV: Life events and psychological stress in dermatological disorders: psoriasis, chronic urticaria, and fungal infections. Br J Med Psychol 53: 277-282, 1980.
3. Gaston L, Lassonde M, Bernier-Buzzanga J, et al: Psoriasis and stress: a prospective study. J Am Acad Dermatol 17: 82-86, 1987.
4. Seville RH: Psoriasis and stress. Br J Dermatol 97: 297-302, 1977.
5. Al'Abadie MS, Kent GG, Gawkrodger DJ: The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 130: 199-203, 1994.
6. Gupta MA, Gupta AK, Ellis CN, et al: Some psychosomatic aspects of psoriasis. Adv Dermatol 5: 21-31, 1990.
7. Vaupel R, Jerry H, Schlomer HT, et al: Differential response of substance P-containing subtypes of adrenomedullary cells to different stressors. Endocrinology 123: 2140-2145, 1988.
8. Blalock JE, Bost KL, Smith ME: Neuroendocrine peptide hormones and their receptors in the immune system production, processing and action. J Neuroimmunol 10: 3140, 1985.
9. Widermann CJ: Shared recognition molecules in the brain and lymphoid tissues: the polypeptide mediator network of psychoneuroimmunology. Immunol Lett 16: 371-378, 1987.
10. Farber EM, Nickoloff BJ, Recht B, et al: Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am Acad Dermatol 14: 305-311, 1986.
11. Farber EM, Lanigan SW, Rein G: The role of psychoneuroimmunology in the pathogenesis of psoriasis. Cutis 46: 314-316, 1990.
12. Raychaudhuri SP, Farber EM: Are sensory nerves essential for the pathogenesis of psoriasis? J Am Acad Dermatol 28: 488-489, 1993.
13. Naukkarinin A, Harvima I, Paukkonen K, et al: Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions. Arch Dermatol Res 285: 341-346, 1993.
14. Eedy DJ, Johnston CF, Shaw C, et al: Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. J Invest Dermatol 96: 434-438, 1991.
15. Raychaudhuri SP, Rein G, Farber EM: Neuropathogenesis and neuropharmacology of psoriasis. Int J Dermatol 34(10): 685-693, 1995.
16. Jowett S, Ryan T: Skin disease and handicap: an analysis of the impact of skin condition. Soc Sci Med 20: 425-429, 1985.
17. Ramsay B, O'Regan M: A survey of the social and psychological effects of psoriasis. Br J Dermatol 118: 195-201, 1988.
18. Fried RG, Friedman S, Paradis C, et al: Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol 34(2): 101-105, 1995.
19. Savin JA: Patients' beliefs about psoriasis. Trans St Johns Hosp Dermatol Soc 56: 139-142, 1970.
20. Lanigan SW, Farber EM: Patient's knowledge of psoriasis: pilot study. Cutis 46(4): 359-362, 1990.
21. Chaput JC, Poynard T, Naveau S, et al: Psoriasis, alcohol and liver disease. BMJ 291: 25, 1985.
22. Poikolainen K, Reunala T, Karvonen J, et al: Alcohol intake: a risk factor for psoriasis in young and middle-aged men? BMJ 300: 780-783, 1990.
23. Vincenti GE, Blunden SM. Psoriasis and alcohol abuse. J R Army Med Corps. 133: 77-78, 1987.
24. Naldi L, Prazzini F, Brevi A, et al: Family history, smoking habits, alcohol consumption, and risk of psoriasis. Br J Dermatol 127: 212-217, 1992.
25. Poikolainen K, Reunala T, Karvonen J, et al: Smoking, alcohol, and life events related to psoriasis among women. Br J Dermatol 130: 473-477, 1994.
26. Mills CM, Srivastava ED, Harvey IM, et al: Smoking habits in psoriasis: a case control study. Br J Dermatol 127: 18-21, 1992.
27. Naldi L, Parazzini P, Peli L, et al: Dietary factors and the risk of psoriasis. Results of an Italian case-control study. Br J Dermatol 134: 101-106, 1996.
28. Hoffman-Goetz L, Pedersen BK: Exercise and the immune system: a model of the stress response? Immunol Today 15(8): 382-387, 1994.
29. Northoff H, Berg A: Immunologic mediators as parameters of the reaction to strenuous exercise. Int J Sports Med 12 (Suppl 1):S9-S15, 1991.
30. Espersen GT, Elback A, Ernst A, et al: Effect of physical on cytokines and lymphocyte subpopulations in human peripheral blood. Acta Pathol Microbiol Immunol Scand 98(5): 395-400, 1990.
31. Waxman D: Behavior therapy of psoriasis - a hypnoanalytic and counter-conditioning technique. Postgrad Med J 49: 591-595, 1973.
32. Kantor SD: Stress and psoriasis. Cutis 46: 321-322, 1990.
33. Hughes HH, Engaland R, Goldsmith DA: Biofeedback and psychotherapeutic treatment of psoriasis: a brief report. Psycho Rep 48: 99-102, 1981.
34. Hawkins J: Benefits of stress management groups. The Practitioner 236: 20-21, 1992.
35. American Heart Association: Exercise Daily. Dallas, American Heart Association, 1990.
36. Farber EM, Nall L: The office visit and the self-help concept in treating the patient with psoriasis: a strategy revisited. Cutis 51: 236-240, 1993.
37. Linden W, Stossel C, Maurice J: Psychosocial interventions for patients with coronary artery disease - a meta-analysis. Arch Intern Med 156: 745-752, 1996.
38. Williams RB, Barefoot JC, Califf RM, et al: Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA 267: 520-524, 1992.